BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/12/2022 8:42:29 AM | Browse: 524 | Download: 1113
 |
Received |
|
2021-11-13 19:45 |
|
Peer-Review Started |
|
2021-11-13 19:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-09 06:05 |
|
Revised |
|
2022-01-22 03:34 |
|
Second Decision |
|
2022-03-18 06:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-03-27 05:28 |
|
Articles in Press |
|
2022-03-27 05:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-24 06:11 |
|
Publish the Manuscript Online |
|
2022-05-12 08:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Novel drug delivery systems for inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Farah Yasmin, Hala Najeeb, Shehryar Shaikh, Muhammad Hasanain, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Syedadeel Hasan and Salim Surani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, FACP, FCCP, MD, MSc, Doctor, Doctor, Professor, Medicine, Texas A&M University, 400 Bizzell St, College Station,, College Station, Texas 77843, United States. srsurani@hotmail.com |
| Key Words |
Inflammation; Inflammatory bowel diseases; Colitis; Ulcerative; Crohn’s disease; Drug delivery systems; Drug carrier |
| Core Tip |
Current literature on novel drug delivery systems is extensive. However, limited content is available that focuses on the novel drug delivery strategies, focally the enteric-coated microneedles pills and biological drug delivery systems. In our review, we discuss multiple novel approaches comprehensively, after outlining the disease course in inflammatory bowel diseases (IBD) and how the conventional routes of drug administrations are deficient in addressing some aspects of disease treatment. We specify that novel carrier systems can be considered for targeting inflamed sites in IBD and discuss the implications of choosing such routes. |
| Publish Date |
2022-05-12 08:42 |
| Citation |
Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for Inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i18/1922.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i18.1922 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
